These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 1906830
1. [Local administration of low-dose estriol and vital Lactobacillus acidophilus in postmenopause]. Kanne B, Jenny J. Gynakol Rundsch; 1991; 31(1):7-13. PubMed ID: 1906830 [Abstract] [Full Text] [Related]
2. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study. Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S. Breast Cancer Res Treat; 2014 Jun; 145(2):371-9. PubMed ID: 24718774 [Abstract] [Full Text] [Related]
3. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Jaisamrarn U, Triratanachat S, Chaikittisilpa S, Grob P, Prasauskas V, Taechakraichana N. Climacteric; 2013 Jun; 16(3):347-55. PubMed ID: 23347400 [Abstract] [Full Text] [Related]
4. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G. BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590 [Abstract] [Full Text] [Related]
6. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S, Ortmann O. Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323 [Abstract] [Full Text] [Related]
7. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial. Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR. Arzneimittelforschung; 1996 Jan; 46(1):68-73. PubMed ID: 8821521 [Abstract] [Full Text] [Related]
10. Transvaginal estriol administration in postmenopausal women: a double blind comparative study of two different doses. Bottiglione F, Volpe A, Esposito G, Aloysio DD. Maturitas; 1995 Nov; 22(3):227-32. PubMed ID: 8746880 [Abstract] [Full Text] [Related]
13. [Treatment of climacteric urogenital disorders with an estriol-containing ointment]. Koloszár S, Kovács L. Orv Hetil; 1995 Feb 12; 136(7):343-5. PubMed ID: 7870416 [Abstract] [Full Text] [Related]
14. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL. Menopause; 2009 Feb 12; 16(5):978-83. PubMed ID: 19390463 [Abstract] [Full Text] [Related]